Prostate cancer: Indicators of aggressiveness

W. A. Sakr, David Grignon

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

In spite of the slow progression rates common to most prostate cancers, it is well recognized that a subset of patients will experience a more aggressive course with many losing their lives to this malignancy. As the number of patients diagnosed with prostate cancer continues to increase, there is a growing pressure to refine and supplement the three most important prognostic parameters for this disease (tumor pathologic stage, its histologic differentiation (Gleason score) and the level of prostate specific antigen). While this review emphasizes the value of these factors in stratifying patients into risk groups, it also explores the prognostic significance of additional commonly used and evolving non-traditional markers (DNA ploidy, proliferation, tumor angiogenesis, and the status of tumor suppressor genes).

Original languageEnglish (US)
Pages (from-to)15-23
Number of pages9
JournalEuropean Urology
Volume32
Issue numberSUPPL. 3
StatePublished - 1997
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Neoplasms
Neoplasm Grading
Ploidies
Prostate-Specific Antigen
Tumor Suppressor Genes
Genetic Markers
Pressure
Prostate Cancer, Hereditary, 7

Keywords

  • DNA ploidy
  • Grade
  • Prognostic markers
  • Prostate cancer
  • Stage

ASJC Scopus subject areas

  • Urology

Cite this

Prostate cancer : Indicators of aggressiveness. / Sakr, W. A.; Grignon, David.

In: European Urology, Vol. 32, No. SUPPL. 3, 1997, p. 15-23.

Research output: Contribution to journalArticle

Sakr, WA & Grignon, D 1997, 'Prostate cancer: Indicators of aggressiveness', European Urology, vol. 32, no. SUPPL. 3, pp. 15-23.
Sakr, W. A. ; Grignon, David. / Prostate cancer : Indicators of aggressiveness. In: European Urology. 1997 ; Vol. 32, No. SUPPL. 3. pp. 15-23.
@article{921675d68a2140e29ac7586128a914cd,
title = "Prostate cancer: Indicators of aggressiveness",
abstract = "In spite of the slow progression rates common to most prostate cancers, it is well recognized that a subset of patients will experience a more aggressive course with many losing their lives to this malignancy. As the number of patients diagnosed with prostate cancer continues to increase, there is a growing pressure to refine and supplement the three most important prognostic parameters for this disease (tumor pathologic stage, its histologic differentiation (Gleason score) and the level of prostate specific antigen). While this review emphasizes the value of these factors in stratifying patients into risk groups, it also explores the prognostic significance of additional commonly used and evolving non-traditional markers (DNA ploidy, proliferation, tumor angiogenesis, and the status of tumor suppressor genes).",
keywords = "DNA ploidy, Grade, Prognostic markers, Prostate cancer, Stage",
author = "Sakr, {W. A.} and David Grignon",
year = "1997",
language = "English (US)",
volume = "32",
pages = "15--23",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Prostate cancer

T2 - Indicators of aggressiveness

AU - Sakr, W. A.

AU - Grignon, David

PY - 1997

Y1 - 1997

N2 - In spite of the slow progression rates common to most prostate cancers, it is well recognized that a subset of patients will experience a more aggressive course with many losing their lives to this malignancy. As the number of patients diagnosed with prostate cancer continues to increase, there is a growing pressure to refine and supplement the three most important prognostic parameters for this disease (tumor pathologic stage, its histologic differentiation (Gleason score) and the level of prostate specific antigen). While this review emphasizes the value of these factors in stratifying patients into risk groups, it also explores the prognostic significance of additional commonly used and evolving non-traditional markers (DNA ploidy, proliferation, tumor angiogenesis, and the status of tumor suppressor genes).

AB - In spite of the slow progression rates common to most prostate cancers, it is well recognized that a subset of patients will experience a more aggressive course with many losing their lives to this malignancy. As the number of patients diagnosed with prostate cancer continues to increase, there is a growing pressure to refine and supplement the three most important prognostic parameters for this disease (tumor pathologic stage, its histologic differentiation (Gleason score) and the level of prostate specific antigen). While this review emphasizes the value of these factors in stratifying patients into risk groups, it also explores the prognostic significance of additional commonly used and evolving non-traditional markers (DNA ploidy, proliferation, tumor angiogenesis, and the status of tumor suppressor genes).

KW - DNA ploidy

KW - Grade

KW - Prognostic markers

KW - Prostate cancer

KW - Stage

UR - http://www.scopus.com/inward/record.url?scp=0030759636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030759636&partnerID=8YFLogxK

M3 - Article

C2 - 9267782

AN - SCOPUS:0030759636

VL - 32

SP - 15

EP - 23

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - SUPPL. 3

ER -